Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Brachytherapy|July 9, 2021
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot studyThomas Reynaud, Lara Hathout, Damien Carignan, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 29, 2020
Mapping the Current State of Canadian Medical School Oncology Interest GroupsNauman H Malik, George J Li, Meredith Giuliani, et al.Brachytherapy|September 15, 2020
Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boostIbtihel Ben Aicha, Lara Hathout, Damien Carignan, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trialAbdenour Nabid, Nathalie Carrier, Eric Vigneault, et al.International Journal of Radiation Oncology, Biology, Physics|April 26, 2021
Optimizing Treatment in Intermediate-Risk Prostate Cancer: Secondary Analysis of a Randomized Phase 3 TrialAbdenour Nabid, Nathalie Carrier, Eric Vigneault, et al.International Journal of Radiation Oncology, Biology, Physics|January 18, 2015
Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysisGraham D Smith, Tom Pickles, Juanita Crook, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2011
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?Gerard Morton, Andrew Loblaw, Patrick Cheung, et al.Advances in Radiation Oncology|November 2, 2019
A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate CancerLara Hathout, Omar Mahmoud, Yaqun Wang, et al.Brachytherapy|October 8, 2023
US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatmentMarie-Claude Lavallee, Audrey Cantin, Sylviane Aubin, et al.Journal of the National Cancer Institute|April 7, 2005
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patientsIsabelle Bairati, François Meyer, Michel Gélinas, et al.Pageof 8